Live
Lonza NewsAcetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.comThermo FisherThermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory10x Genomics Blog10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0Lonza NewsSimulations Plus partners with Lonza and FDA on drug formulation research - Investing.com AustraliaIlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - IlluminaFierceBiotechAACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave risesFierceBiotechRacing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS datasetFierceBiotechRoche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trialsRoche MediaRoche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials - Fierce BiotechLonza NewsProject Hope Foundation receives $50K donation from Lonza Capsugel - Greenville JournalHarvard BioscienceHarvard Bioscience (HBIO) 2026 proxy details director elections and equity plans - Stock TitanFierceBiotechPulnovo Medical scores $100M in finance round led by Medtronic
BioPharma Dive 26 nov. 2025

Otsuka gains approval for first-of-its-kind treatment against rare kidney disease

Otsuka gains approval for first-of-its-kind treatment against rare kidney disease

Original
Contenu indisponible. Consultez la source originale.